in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
ScinoPharm Signs API Manufacturing Deal with Clinical Data
11:39 PM MST | February 13, 2011 | Deepti Ramesh
Active pharmaceutical ingredients (APIs) manufacturer and contract research and manufacturing services (CRAMS) company ScinoPharm (Shan-Hua, Taiwan) says it will provide commercial manufacturing service for vilazodone hydrochloride API for Clinical Data’s (Newton, MA) Viibryd. Viibryd is a new drug entity recently approved by the U.S. Food and Drug Administration for the treatment of major depressive disorder in adults. ScinoPharm says it is set to expand its CRAM services through its new plant at Changshu, China, which is expected to be operational in the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee